Removal of Cannabis from the German Narcotics List: What does that mean?

Join us as we introduce a diverse panel, bringing together
different perspectives of the industry, to provide their insights
on what the removal of cannabis from the German Narcotics List
really means. What changes are to be expected by patients,
pharmacists, physicians and the industry as a whole? Does the
reclassification provide opportunities for the industry or is it
just another reason for hype? We will take a closer look at this
decision by the German government and discuss its
implications.



Language: German



Speakers



Bijan Christoph Hezarkhani (Moderator),
BijanChristoph.com, Business Development


Dr. Armin Prasch, (Speaker), Trias Pharma
GmbH, CEO


Thorsten Hetfeld (Speaker), CannaTHoC
Cannabis-Association, Founder


Melanie Dolfen, (Speaker), Bezirksapotheken
Berlin, Pharmacist & Owner & Entrepreneur


Garvin Hirt (Speaker), Copeia, Founding
Partner